JS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of thioredoxin reductase 1
about
Identification of S-nitrosylated targets of thioredoxin using a quantitative proteomic approachDual targeting of the thioredoxin and glutathione systems in cancer and HIV.Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunctionGlutathione S -transferase π: a potential role in antitumor therapy
P2860
JS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of thioredoxin reductase 1
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
JS-K, a nitric oxide prodrug, ...... own of thioredoxin reductase 1
@ast
JS-K, a nitric oxide prodrug, ...... own of thioredoxin reductase 1
@en
JS-K, a nitric oxide prodrug, ...... wn of thioredoxin reductase 1.
@nl
type
label
JS-K, a nitric oxide prodrug, ...... own of thioredoxin reductase 1
@ast
JS-K, a nitric oxide prodrug, ...... own of thioredoxin reductase 1
@en
JS-K, a nitric oxide prodrug, ...... wn of thioredoxin reductase 1.
@nl
prefLabel
JS-K, a nitric oxide prodrug, ...... own of thioredoxin reductase 1
@ast
JS-K, a nitric oxide prodrug, ...... own of thioredoxin reductase 1
@en
JS-K, a nitric oxide prodrug, ...... wn of thioredoxin reductase 1.
@nl
P2093
P2860
P1433
P1476
JS-K, a nitric oxide prodrug, ...... own of thioredoxin reductase 1
@en
P2093
Kornelia Edes
Pamela Cassidy
Paul J Shami
Philip J Moos
P2860
P356
10.1371/JOURNAL.PONE.0008786
P407
P577
2010-01-20T00:00:00Z